Andres Liivak is a partner in the firm's life sciences and healthcare practice in the New York office of the firm. Andres's practice focuses on health technology transactions, advising global pharmaceutical companies as well as biotechnology, medical device and other health technology concerns worldwide.
Andres designs, structures and negotiates complex collaborations, licensing, commercial arrangements and M&A transactions. Andres helps put in place arrangements for hybrid royalty profit/cost-sharing, product risk and opportunity sharing, varying allocations across multiple territories, conditional option rights and acquisition options, each of which are becoming increasingly prevalent. Andres also counsels clients on contentious transactional matters, including complex settlements of commercial and intellectual property disputes involving health technology.
Andres draws on his experience with pharmaceutical, biotech and medical device operations to work on emerging advanced health technologies. He works on health monitoring diagnostic wearables and related health data driven innovation. His multiple projects on advanced therapeutic treatment processes have given him unique experience with the apheresis related technologies used in many emerging immunotherapies and a working knowledge for the special technical, regulatory and commercialization challenges that are present.
Working within Norton Rose Fulbright's global legal practice, the firm's compelling platform helps Andres provide his clients with an integrated solution to the ever changing set of disruptive challenges to their business objectives. In particular, the combination of privacy, healthcare regulatory, competition and IP advice – globally – is increasingly important to successfully undertaking such health technology deals. Norton Rose Fulbright provides that solution.
Known for his collaborative approach and commitment to client service, Andres facilitates and enables deals by listening and appreciating the context to develop creative, effective solutions while driving deals to completion efficiently.
Andres is recognized by Legal 500 US for his work in life sciences and healthcare and as a "Life Science Star" in Euromoney's LMG Life Sciences Guide. He has also been recognized in Who's Who Legal's The International Who's Who of Life Sciences 2014, and he is recommended by PLC Which Lawyer as being among the leading lawyers throughout the US for Life Sciences: Commercial and Partnering.